1 of 1
Story summary
- At CES 2026, Withings announced the Body Scan 2 smart scale, priced at $599.95.
- It measures over 60 biomarkers, including hypertension risk and glycemic dysregulation, using Impedance Cardiography and Bioimpedance Spectroscopy.
- The device includes a retractable handle for upper-body data and a Health Trajectory score to track long-term health trends.
- The Body Scan 2 launch is expected in Q2 2026, pending FDA clearance for certain metrics.
